The current MGNX market cap is 919M. The company's latest EPS is USD -1.9182 and P/E is -7.67.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 41.73M | 73.1M | 24.5M | 13.14M | 10.4M |
Operating Income | -24.96M | 11.98M | -38.43M | -44.96M | -35.5M |
Net Income | -24.81M | 12.8M | -38.01M | 57.47M | 17.55M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 60.12M | 64.19M | 104.88M | 77.45M | 151.94M |
Operating Income | -171.21M | -177.19M | -131.06M | -202.8M | -121.42M |
Net Income | -171.45M | -151.81M | -129.74M | -202.12M | -119.76M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 195.35M | 280.47M | 343.5M | 305.65M | 339.97M |
Total Liabilities | 72.39M | 138.46M | 234.23M | 134.11M | 145.99M |
Total Equity | 122.96M | 142.01M | 109.27M | 171.54M | 193.98M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 332.13M | 312.5M | 378.74M | 335.25M | 280.47M |
Total Liabilities | 89.25M | 81.87M | 82.86M | 95.63M | 138.46M |
Total Equity | 242.88M | 230.63M | 295.88M | 239.62M | 142.01M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -116.28M | -86.96M | -12.83M | -14.92M | -50.17M |
Investing | 76.5M | 70.72M | 28.1M | -85.38M | -118.91M |
Financing | 300k | 1.66M | 100.12M | 100.18M | 150.09M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -153.23M | -134.27M | -111.9M | -143.83M | -86.96M |
Investing | 56.64M | -79.36M | -7.79M | -36.61M | 70.72M |
Financing | 104.99M | 119.97M | 174.34M | 122.78M | 1.66M |
Market Cap | 919M |
Price to Earnings Ratio | -7.67 |
Price to Sales Ratio | 6.05 |
Price to Cash Ratio | 8.44 |
Price to Book Ratio | 6.47 |
Dividend Yield | - |
Shares Outstanding | 62.43M |
Average Volume (1 week) | 870.62k |
Average Volume (1 Month) | 1.89M |
52 Week Change | 117.75% |
52 Week High | 21.88 |
52 Week Low | 4.29 |
Spread (Intraday) | 1.43 (9.61%) |
Company Name | MacroGenics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.macrogenics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.